Registered entities
Immusoft Corporation
Reg. No. -Belgium
Social engagement
Social engagement: 3.6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
25 investors on record; lead investors include 600 Mile Challenge Fund, Breakout Ventures, Mesa Verde Venture Partners, Ikarian Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 20 | 80% |
| Other / undisclosed | 5 | 20% |
Recent activity
6 May 2026
Event
American Society of Gene & Cell Therapy Annual Meeting
16 Apr 2026
Event
Life Science Innovation Northwest 2026 conference
8 Apr 2026
Event
Advancing Pediatric Cell and Gene Therapy Clinical Trials